Skip to main content
. 2022 Sep 23;10(4):54. doi: 10.3390/medsci10040054

Table 2.

Overall histology.

Staging

  • Malignant, n = 53 (85.4%)

  • Adenocarcinoma, n = 51 (82.2%)

  • Large cell carcinoma, n = 1 (1.6%)

  • Typical carcinoid, n = 1 (1.6%)

  • Benign, n = 9 (14.6%)

  • Chronic flogosis

  • Stage IA 1, n = 33 (62.3%)

  • Stage IA 2, n = 15 (28.4%)

  • Stage IA 3, n = 3 (5.6%)

  • Stage II B (N1 positive), n = 2 (3.7%)